Cushing's disease is rare, with an estimated incidence of 2 to 8 cases per million per year, yet untreated or undertreated hypercortisolism carries a standardized mortality ratio of 3.0, and cardiovascular events account for 43.4% of deaths. Diagnostic delay averages three to six years because the classic phenotype of moon facies and central obesity is frequently absent in adults 65 and older, who instead present with resistant hypertension, difficult-to-control diabetes, and unexplained fractures. Recognizing this atypical presentation and documenting etiologic specificity precisely are among the highest-value clinical actions a primary care team can take.
AAVBC's Cushing's Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 etiologic specificity across pituitary, adrenal, ectopic, and drug-induced Cushing's syndrome, HCC/RAF V28 mapping, diagnostic thresholds for salivary cortisol, urinary free cortisol, and ACTH testing, MEAT documentation standards, therapy escalation from transsphenoidal surgery through steroidogenesis inhibitors, medication safety monitoring, and comorbidity management. Grounded in Pituitary Society 2021 and Endocrine Society 2015 guidance, this guide supports consistent, individualized clinical decision-making, helping care teams shorten diagnostic delay and document the full multisystem burden of hypercortisolism, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of Cushing's disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Cushing's disease is rare, with an estimated incidence of 2 to 8 cases per million per year, yet untreated or undertreated hypercortisolism carries a standardized mortality ratio of 3.0, and cardiovascular events account for 43.4% of deaths. Diagnostic delay averages three to six years because the classic phenotype of moon facies and central obesity is frequently absent in adults 65 and older, who instead present with resistant hypertension, difficult-to-control diabetes, and unexplained fractures. Recognizing this atypical presentation and documenting etiologic specificity precisely are among the highest-value clinical actions a primary care team can take.
AAVBC's Cushing's Disease Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering ICD-10 etiologic specificity across pituitary, adrenal, ectopic, and drug-induced Cushing's syndrome, HCC/RAF V28 mapping, diagnostic thresholds for salivary cortisol, urinary free cortisol, and ACTH testing, MEAT documentation standards, therapy escalation from transsphenoidal surgery through steroidogenesis inhibitors, medication safety monitoring, and comorbidity management. Grounded in Pituitary Society 2021 and Endocrine Society 2015 guidance, this guide supports consistent, individualized clinical decision-making, helping care teams shorten diagnostic delay and document the full multisystem burden of hypercortisolism, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of Cushing's disease — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
